TH588

1 1

Selleck Chemicals

S7632-5MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

TH588 is an inhibitor linked to DNA Damage Response and related pathway-oriented research. In practice, this places the compound in experiments that measure checkpoint activation, DNA repair, and genome-stability control in cancer and dna damage / repair models.

The pathway annotation connects TH588 to DNA Damage Response, supporting experiments that monitor checkpoint activation, DNA repair, and genome-stability control across biochemical, cellular, or phenotypic assay formats. This context is compatible with DNA-repair, checkpoint, and genotoxic-stress assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cancer and dna damage / repair models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to DNA Damage Response
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in cancer and dna damage / repair models
  • Combination studies with orthogonal perturbagens

Overall, TH588 is well suited to pathway-oriented studies that need a defined compound input for DNA Damage Response readouts in cancer and dna damage / repair models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
DNA Damage Response
Research Area:
Cancer • DNA Damage / Repair
CAS No.:
1609960-31-7
Molecular Weight:
295.17
Formula:
C₁₃H₁₂Cl₂N₄
SMILES:
C1CC1NC2=NC(=NC(=C2)C3=C(C(=CC=C3)Cl)Cl)N
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.